Key result
Chemotherapy with COP, R-CHOP, and R-CHASE resulted in complete remission of primary cardiac B cell lymphoma, which was sustained for 1 year.
Why the study?
Primary cardiac lymphoma is rare and increasingly seen in immunocompromised hosts, but a considerable proportion still occurs in immunocompetent patients.
Population
A 55-year-old immunocompetent Japanese man with primary cardiac B cell lymphoma
Design
Case report
Authors
Loading...
May support chemotherapy in primary cardiac B-cell lymphoma; leaves open need for confirmatory studies before practice change.
Case Report (n=1)
Primary cardiac B cell lymphoma can be successfully treated with chemotherapy, and multimodality imaging including optical coherence tomography is valuable for assessing tumor extension and predicting ischemic complications.
Miyawaki et al. (2021) conducted a case report in Primary cardiac B cell lymphoma (n=1). Chemotherapy (COP, R-CHOP, R-CHASE) was evaluated on Tumor response. Chemotherapy with COP, R-CHOP, and R-CHASE resulted in complete remission of primary cardiac B cell lymphoma, which was sustained for 1 year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: